➤ Signal

Capital is treating medical office as a core defensive sleeve, not an alternative — and scale is consolidating into a few large platforms.

While office repositions and hospitality reprices labor, medical office is doing the quiet thing institutional capital prizes: compounding. A 93% occupancy print — a ten-year high — is the kind of stat that moves allocation, not just sentiment.

The pending Remedy/Kayne combination matters structurally. Adding ~18M SF in one transaction signals the sector is consolidating into a handful of operators with the scale to serve national health systems.

Demand is demographic, not cyclical. An aging population and the steady shift of care from inpatient to outpatient settings give MOB a tailwind that’s largely independent of rate moves — exactly why it reads as defensive in a choppy year.

For investors rotating out of commodity office, MOB offers duration and credit quality — but entry pricing is firming as occupancy peaks. The edge now is in development and value-add near health-system anchors, not buying stabilized at a full price.